Local News: Indian River Shor... 

 | 

Sign Up

 | 

Sign In

Advertisment

Meridia, Sibutramine

Meridia, Sibutramine Wire

Comprehensive News Feed for Meridia, Sibutramine (generic).

Results 1 - 20 of 250 in Meridia, Sibutramine (generic)

  1. FDA Reviews Safety of Diet Drug MeridiaRead the original story

    2 hrs ago | WebMD Health News

    Nov. 23, 2009 -- A new study of the weight loss drug Meridia is in the hands of FDA regulators, who've released an early communication based on preliminary data: certain patients taking the drug may have a higher risk of heart attacks , strokes, and other serious cardiovascular problems.

    Comment?

    Related Topix: Medicine, Medication, Biotech, Abbott Laboratories

  2. Sibutramine May Increase Cardiovascular-Event RiskRead the original story

    5 hrs ago | ASHP

    Preliminary data from a placebo-controlled, 10,000-patient study suggest that the antiobesity drug sibutramine may increase patients' risk of cardiovascular adverse events, FDA announced on Friday.

    Comment?

    Related Topix: Medicine, Medication, Healthcare Law, Law

  3. FDA MedWatch - Meridia (sibutramine): Early Communication about cardiovascular eventsRead the original story

    13 hrs ago | Drugs.com

    ROCKVILLE, Nov. 21, 2009-FDA notified healthcare professionals and patients that it is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events than patients using a placebo .

    Comment?

    Related Topix: Medicine, Stroke, Life, Food, Dieting, Events

  4. FDA Investigating Possible Link Between Sibutramine and Cardiovascular EventsRead the original story

    14 hrs ago | Journal Watch - Medicine that Matters

    The FDA has issued an early communication regarding a possible increased risk for adverse cardiovascular events associated with sibutramine , a prescription drug used to manage obesity.

    Comment?

    Related Topix: Medicine, Medication

  5. FDA investigates popular weight loss drug, MeridiaRead the original story w/Photo

    Wednesday Nov 18 | Examiner.com

    The Food and Drug Administration is investigating the possibility that the weight loss drug, Meridia , may increase the risks of cardiovascular events.

    Comment?

    Related Topix: Medicine, Medication, Food and Drug Administration

  6. Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety ReviewRead the original story

    Thursday Nov 19 | Drugs.com

    Sibutramine is marketed as Meridia, a prescription drug, in the United States. Meridia was approved by FDA in 1997 for the management of obesity, including weight loss and maintenance of weight loss, in conjunction with a reduced calorie diet.

    Comment?

    Related Topix: Medicine, Medication, Life, Food, Dieting

  7. Dietary Supplement recallRead the original story w/Photo

    Friday Nov 13 | WPVI-TV Philadelphia

    GMP Herbal Products Inc. is recalling Pai You Guo, a weight loss dietary supplement, because it contains drug ingredients not declared on the label.

    Comment?

    Related Topix: Medicine, Medication, Food and Drug Administration

  8. Health News: Exclusive: Record numbers of Scots being prescribed anti-obesity drugsRead the original story

    Saturday | The Daily Record

    RECORD numbers of obese Scots are being given fat-busting drugs costing 4million a year.

    Comment?

  9. Meridia Side Effects - FDA says weight loss drug sibutramine may cause heart attack and strokeRead the original story w/Photo

    Saturday | Examiner.com

    The U.S. Food and Drug Administration is conducting a review of the weight loss medication sibutramine, marketed in prescription form as Meridia, due to a recent study suggesting heart problems may be associated with the medication.

    Comment?

    Related Topix: Medicine, Medication, Food and Drug Administration

  10. FDA review diet drug risksRead the original story

    Friday Nov 20 | The Straits Times

    US REGULATORS are reviewing preliminary data suggesting patients taking Abbott Laboratories Inc's weight loss drug Meridia may have a higher risk of cardiovascular problems, the Food and Drug Administration said on Friday.

    Comment?

    Related Topix: Food and Drug Administration, Biotech, Abbott Laboratories, Medicine, Medication

  11. Early Communication about an Ongoing Safety Review of MeridiaRead the original story w/Photo

    Friday Nov 20 | Bioscience Technology

    Early Communication about an Ongoing Safety Review ofA A Meridia This information reflects FDA's current analysis of available data concerning this drug.

    Comment?

    Related Topix: Medicine, Medication, Healthcare Law, Law

  12. Abbott's diet drug's risks have FDA's attention

    Friday Nov 20 | Chicago Business

    "The analysis of these data is ongoing and FDA is making no conclusions about the preliminary findings at this time," the agency said in a statement.

    Comment?

    Related Topix: Biotech, Abbott Laboratories, Food and Drug Administration, Medicine, Medication, Abbott Laboratories, Business News

  13. More studies needed on possible fibromyalgia drugRead the original story

    Tuesday Nov 10 | The Spokesman-Review

    DEAR DR. GOTT: I am writing to you because of your willingness to share information on remedies that have been reported successful by your readers.

    Comment?

    Related Topix: Fibromyalgia, Health, Medicine, Medication, Arthritis

  14. Dietary Supplement recall

    Friday Nov 13 | WPVI-TV Philadelphia

    GMP Herbal Products Inc. is recalling Pai You Guo, a weight loss dietary supplement, because it contains drug ingredients not declared on the label.

    Comment?

    Related Topix: Medicine, Medication, Food and Drug Administration

  15. FDA targets GMP Herbal Products over weight-loss dietary supplementRead the original story

    Tuesday Nov 17 | Drug Store News

    WESTMINSTER,A Calif. The Food and Drug Administration moved against another online marketer purporting to sell a dietary supplement weight-loss product last week.

    Comment?

    Related Topix: Food and Drug Administration, Marketing

  16. Pai You Guo Weight Loss Supplement RecalledRead the original story

    Monday Nov 16 | Personal Injury Law News

    The U.S. Food and Drug Administration informed GMP Herbal Products, Inc. that its weight loss dietary supplement, sold and marketed as Pai You Guo, contains undeclared ingredients.

    Comment?

    Related Topix: Food and Drug Administration

  17. FDA targets GMP Herbal Products over weight loss dietary supplementRead the original story

    Monday Nov 16 | Drug Store News

    WESTMINSTER,A Calif. The Food and Drug Administration moved against another online marketer purporting to sell a dietary supplement weight-loss product last week.

    Comment?

    Related Topix: Food and Drug Administration, Marketing

  18. Doctor admits forging drug prescriptions for herselfRead the original story

    Sunday Nov 15 | The Otago Daily Times

    A young doctor has admitted to forging prescriptions for weight-loss drugs to help keep her awake during long working hours.

    Comment?

  19. Pai You Guo, Marketed as Dietary Supplement - RecallRead the original story

    Thursday Nov 12 | Drugs.com

    FDA lab analyses of dietary supplements were found to contain undeclared sibutramine, an FDA-approved drug used as an appetite suppressant for weight loss; and phenolphthalein, a solution used in chemical experiments and a suspected cancer-causing agent that is not approved for marketing in the United States.

    Comment?

    Related Topix: Food and Drug Administration, Medicine, Medication, Marketing

  20. California Company Recalls Weight Loss Supplement

    Friday Nov 13 | ConsumerAffairs.Com

    A California company has recalled a weight loss supplement because it contains two undeclared ingredients that pose a health risk.

    Comment?

    Related Topix: Food and Drug Administration, Medicine, Medication, Marketing